SIVA1 and non-small cell lung carcinoma: Earlier studies using animal models showed that conditional inactivation of Siva in an autochthonous oncogenic KRASG12D–driven mouse model for non-small cell lung cancer (NSCLC) decreased tumor numbers and tumor burden relative to Siva-expressing controls.